{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:02:51Z","timestamp":1762542171212,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T00:00:00Z","timestamp":1369958400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.6061\/clinics\/2013(05)010","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T09:11:12Z","timestamp":1369041072000},"page":"638-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ"],"prefix":"10.1016","volume":"68","author":[{"given":"Fernando N.","family":"Aguiar","sequence":"first","affiliation":[]},{"given":"Henrique N.","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Cinthya S.","family":"Cirqueira","sequence":"additional","affiliation":[]},{"given":"Carlos E.","family":"Bacchi","sequence":"additional","affiliation":[]},{"given":"Filomena M.","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.6061\/clinics\/2013(05)010_bib1","unstructured":"Tavassoli F, Devilee P. Wordl Health Organization of Tumors: Pathology and genetics of tumors of the breast and female genital organs. IARC WHO Classification of Tumours (Book 4), 2003."},{"issue":"20","key":"10.6061\/clinics\/2013(05)010_bib2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","article-title":"Detection of ductal carcinoma in situ in women undergoing screening mammography","volume":"94","author":"Ernster","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.6061\/clinics\/2013(05)010_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1006453420088","article-title":"Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy","volume":"60","author":"Ottesen","year":"2000","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.6061\/clinics\/2013(05)010_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1078-0432.CCR-07-1127","article-title":"Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution","volume":"14","author":"Allred","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.6061\/clinics\/2013(05)010_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.pathol.4.110807.092306","article-title":"Preinvasive breast cancer","volume":"5","author":"Sgroi","year":"2010","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.6061\/clinics\/2013(05)010_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/SLA.0b013e3181b5931e","article-title":"The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy","volume":"251","author":"Rudloff","year":"2010","journal-title":"Ann Surg"},{"issue":"41","key":"10.6061\/clinics\/2013(05)010_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jncimonographs\/lgq025","article-title":"Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective","volume":"2010","author":"Bijker","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"4","key":"10.6061\/clinics\/2013(05)010_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","article-title":"Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ","volume":"200","author":"Yen","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"2","key":"10.6061\/clinics\/2013(05)010_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/modpathol.3800528","article-title":"Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma","volume":"19","author":"Livasy","year":"2006","journal-title":"Mod Pathol"},{"issue":"7","key":"10.6061\/clinics\/2013(05)010_bib10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/PAS.0b013e3181e02f45","article-title":"Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers","volume":"34","author":"Thike","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.6061\/clinics\/2013(05)010_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/030089160909500110","article-title":"Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype","volume":"95","author":"Liu","year":"2009","journal-title":"Tumori"},{"issue":"2","key":"10.6061\/clinics\/2013(05)010_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.humpath.2006.08.017","article-title":"Identification of a basal-like subtype of breast ductal carcinoma in situ","volume":"38","author":"Livasy","year":"2007","journal-title":"Hum Pathol"},{"issue":"1","key":"10.6061\/clinics\/2013(05)010_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.6061\/clinics\/2013(05)010_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/bcr1041","article-title":"Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer","volume":"7","author":"Gusterson","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.6061\/clinics\/2013(05)010_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/modpathol.3880483","article-title":"Expression of cytokeratin 5\/6 in epithelial neoplasms: an immunohistochemical study of 509 cases","volume":"15","author":"Chu","year":"2002","journal-title":"Mod Pathol"},{"issue":"3","key":"10.6061\/clinics\/2013(05)010_bib16","first-page":"256","article-title":"Complex cytokeratin polypeptide patterns observed in certain human carcinomas","volume":"23","author":"Moll","year":"1983","journal-title":"Differentiation"},{"issue":"3","key":"10.6061\/clinics\/2013(05)010_bib17","first-page":"571","article-title":"Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast","volume":"134","author":"Wetzels","year":"1989","journal-title":"Am J Pathol"},{"issue":"8531","key":"10.6061\/clinics\/2013(05)010_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(87)92129-5","article-title":"Monoclonal marker that predicts early recurrence of breast cancer","volume":"1","author":"Dairkee","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.6061\/clinics\/2013(05)010_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s004280050226","article-title":"Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas","volume":"433","author":"Malzahn","year":"1998","journal-title":"Virchows Arch"},{"issue":"6797","key":"10.6061\/clinics\/2013(05)010_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.6061\/clinics\/2013(05)010_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"10.6061\/clinics\/2013(05)010_bib22","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.6061\/clinics\/2013(05)010_bib23","first-page":"444","article-title":"Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers","volume":"2","author":"Bhargava","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"10.6061\/clinics\/2013(05)010_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.3800570","article-title":"Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer","volume":"19","author":"Bryan","year":"2006","journal-title":"Mod Pathol"},{"issue":"2","key":"10.6061\/clinics\/2013(05)010_bib25","first-page":"127","article-title":"Expression of cytokeratin markers, ER-alpha, PR, HER-2\/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast","volume":"37","author":"Steinman","year":"2007","journal-title":"Ann Clin Lab Sci"},{"key":"10.6061\/clinics\/2013(05)010_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/1471-2407-10-653","article-title":"Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study","volume":"10","author":"Zhou","year":"2010","journal-title":"BMC Cancer"},{"issue":"41","key":"10.6061\/clinics\/2013(05)010_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jncimonographs\/lgq020","article-title":"The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast","volume":"2010","author":"Solin","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.6061\/clinics\/2013(05)010_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7150\/jca.2.232","article-title":"Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review","volume":"2","author":"Lari","year":"2011","journal-title":"J Cancer"},{"issue":"1","key":"10.6061\/clinics\/2013(05)010_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-011-1387-4","article-title":"Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis","volume":"127","author":"Wang","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"41","key":"10.6061\/clinics\/2013(05)010_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jncimonographs\/lgq035","article-title":"Ductal carcinoma in situ: terminology, classification, and natural history","volume":"2010","author":"Allred","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"41","key":"10.6061\/clinics\/2013(05)010_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jncimonographs\/lgq031","article-title":"Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics","volume":"2010","author":"Schnitt","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"6","key":"10.6061\/clinics\/2013(05)010_bib32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.breast.2005.08.007","article-title":"Sentinel lymph node biopsy for localised ductal carcinoma in situ","volume":"14","author":"Veronesi","year":"2005","journal-title":"Breast"},{"issue":"4","key":"10.6061\/clinics\/2013(05)010_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4048\/jbc.2011.14.4.301","article-title":"Ductal carcinoma in situ and sentinel lymph node biopsy","volume":"14","author":"Son","year":"2011","journal-title":"J Breast Cancer"},{"issue":"Suppl 2","key":"10.6061\/clinics\/2013(05)010_bib34","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/modpathol.2010.53","article-title":"Clinical applications of breast pathology: management of in situ breast carcinomas and sentinel node biopsy issues","volume":"23","author":"Smith","year":"2010","journal-title":"Mod Pathol"},{"issue":"7","key":"10.6061\/clinics\/2013(05)010_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12094-010-0543-3","article-title":"Sentinel lymph node biopsy in selected cases of ductal carcinoma in situ","volume":"12","author":"Collado","year":"2010","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"10.6061\/clinics\/2013(05)010_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.3800360","article-title":"HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy","volume":"18","author":"Collins","year":"2005","journal-title":"Mod Pathol"},{"issue":"6","key":"10.6061\/clinics\/2013(05)010_bib37","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/bjc.2012.41","article-title":"HER2\/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ","volume":"106","author":"Rakovitch","year":"2012","journal-title":"Br J Cancer"},{"issue":"3","key":"10.6061\/clinics\/2013(05)010_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clon.2011.09.008","article-title":"Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence","volume":"24","author":"Han","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"10.6061\/clinics\/2013(05)010_bib39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jso.21973","article-title":"The significance of HER-2\/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease","volume":"104","author":"Harada","year":"2011","journal-title":"J Surg Oncol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222017227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222017227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-68-05\/cln-68-05-638.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:06:18Z","timestamp":1761721578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222017227"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322013000500638&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3654300\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1807593222017227"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2013(05)010","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2013(05)010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}